Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The current landscape of treatment for frail myeloma patients at relapse & challenges in this space

In this video, Clark DuMontier, MD, MPH, VA Boston Healthcare System, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, discusses the challenges of optimizing treatment for elderly and frail patients with multiple myeloma at relapse. Dr DuMontier mentions the shift from prolongation of survival to preservation of quality of life (QoL) as patients age. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.